Confirmed Safety of Deutetrabenazine for Tardive Dyskinesia in a 2-Year Open-Label Extension Study

被引：0
|
作者：
Fernandez, Hubert H. [1 ]
Stamler, David [2 ]
Davis, Mat D. [2 ]
Factor, Stewart A. [3 ]
Hauser, Robert A. [4 ]
Jimenez-Shahed, Joohi [5 ]
Ondo, William G. [6 ,7 ]
Jarskog, L. Fredrik [8 ]
Woods, Scott W. [9 ]
LeDoux, Mark S. [10 ]
Shprecher, David R. [11 ]
Anderson, Karen E. [12 ]
机构：
[1] Cleveland Clin, Ctr Neurol Restorat, Cleveland, OH 44106 USA
[2] Teva Pharmaceut Ind, La Jolla, CA USA
[3] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[4] Movement Disorders Ctr, Tampa, FL USA
[5] Parkinsons Dis Ctr & Movement Disorders Clin, Houston, TX USA
[6] Methodist Neurol Inst, Houston, TX USA
[7] Weill Cornell Med Coll, Houston, TX USA
[8] Univ North Carolina, Sch Med, Chapel Hill, NC 27515 USA
[9] Yale Sch Med, New Haven, CT USA
[10] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA
[11] Banner Sun Hlth Res Inst, Sun City, AZ USA
[12] Georgetown Univ, Washington, DC USA
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P4.075
引用
收藏
页数：3
相关论文
共 50 条
  • [41] EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinsons Disease
    Tanner, Caroline M.
    Pahwa, Rajesh
    Hauser, Robert A.
    Oertel, Wolfgang H.
    Isaacson, Stuart H.
    Jankovic, Joseph
    Johnson, Reed
    Chernick, Dustin
    Hubble, Jean
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (02) : 543 - 558
  • [42] Effect of lurasidone on cognition in children and adolescents with bipolar depression: Interim analysis of a 2-year open-label extension study
    Burdick, K. E.
    Goldman, R.
    Tocco, M.
    Deng, L.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S367 - S368
  • [43] Safety and effectiveness of long-term treatment with lurasidone in children and adolescents with bipolar depression: Interim analysis of a 2-year open-label extension study
    DelBello, M. P.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    BIPOLAR DISORDERS, 2019, 21 : 133 - 133
  • [44] Safety of long-term treatment with lurasidone in children and adolescents with bipolar depression: week 28 results of a 2-year open-label extension study
    Chang, K.
    DelBello, M.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    BIPOLAR DISORDERS, 2018, 20 : 66 - 66
  • [45] Kinect 4: A Phase 3, One-Year, Open-Label Trial of Valbenazine in Participants With Tardive Dyskinesia
    Marder, Stephen
    Kane, John
    Factor, Stewart
    Jimenez, Roland
    Thai-Cuarto, Dao
    Liang, Grace
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S396 - S397
  • [46] Long-term safety of an extended-cycle oral contraceptive (Seasonate): A 2-year multicenter open-label extension trial
    Anderson, F. D.
    Gibbons, William
    Portman, David
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (01) : 92 - 96
  • [47] Safety and Efficacy of Long-Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open-Label Extension Study
    Jankovic, Joseph
    Coffey, Barbara
    Claassen, Daniel O.
    Jimenez-Shahed, Joohi
    Gertz, Barry J.
    Garofalo, Elizabeth A.
    Stamler, David A.
    Wieman, Maria
    Savola, Juha-Matti
    Harary, Eran
    Alexander, Jessica
    Barkay, Hadas
    Gordon, Mark Forrest
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2023, 10 (09): : 1388 - 1398
  • [48] Photodynamic therapy with verteporfin in ocular histoplasmosis: Uncontrolled, open-label 2-year study
    Rosenfeld, PJ
    Saperstein, DA
    Bressler, NM
    Reaves, TA
    Sickenberg, M
    Rosa, RH
    Sternberg, P
    Aaberg, TM
    Aaberg, TM
    OPHTHALMOLOGY, 2004, 111 (09) : 1725 - 1733
  • [49] Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: An open-label study
    Miyaoka, Tsuyoshi
    Furuya, Motollide
    Yasuda, Hideaki
    Hayashida, Maiko
    Nishida, Akira
    Inagaki, Takuji
    Horiguchi, Jun
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (03): : 761 - 764
  • [50] Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study
    Liu, Kun
    Wang, Hanying
    He, Wei
    Ye, Jian
    Song, Yanping
    Wang, Yusheng
    Liu, Xiaoling
    Wu, Zhifeng
    Chen, Shaojun
    Fan, Ke
    Liu, Yuling
    Zhang, Feng
    Li, Zhiqing
    Liu, Lin
    Zhang, Junjun
    Zhang, Xuedong
    Ye, Junjie
    Liang, Xiaoling
    Li, Xiaoxin
    Ke, Xiao
    Wu, Quan
    Li, Jie
    Tao, Shanshan
    Wang, Xinguo
    Rosenfeld, Philip
    Heier, Jeffrey S.
    Kaiser, Peter
    Xu, Xun
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2022, 106 (10) : 1436 - 1443
12345